© 2000 by Oxford University Press and the Maryland Psychiatric Research Center (MPRC)
Prevalence and Correlates of Diabetes in National Schizophrenia Samples
Department of Pyschiatry, University of Maryland Baltimore, MD
State University of New York Health Science Center Brooklyn, New York
Department of Pyschiatry, University of Maryland Baltimore, MD
Department of Pyschiatry, University of Maryland Baltimore, MD
Department of Pyschiatry, University of Maryland Baltimore, MD
Department of Pyschiatry, University of Maryland Baltimore, MD
Department of Pyschiatry, University of Maryland Baltimore, MD
Send reprint requests to Dr. L. Dixon, University of Maryland, Dept. of Psychiatry, 701 West Pratt St., Rm. 476, Baltimore, MD 21201; e-mail: ldixon{at}umaryland.edu
People with schizophrenia may be at increased risk for Type II diabetes because of the side effects of antipsychotic medication, poorer overall physical health, less healthy lifestyles, and poorer health care. The present study uses data bases collected by the Schizophrenia Patient Outcomes Research Team (PORT) to assess the prevalence and demographic and clinical correlates of diabetes within large populations of persons receiving treatment for schizophrenia. In the Schizophrenia PORT, Medicaid and Medicare data from 1991 and more recent interview data were collected regarding the comorbidity of schizophrenia and diabetes: prevalence, quality of life, physical health, and services utilization and costs. The study found that rates of diagnosed diabetes exceeded general population statistics well before the widespread use of the new antipsychotic drugs. Risk factors for diabetes were similar to those observed in the general population. The linkage of diabetes to poor physical health, medical morbidity, and increased service use and cost requires attention. This study of diabetes in the early 1990s suggests that even before the widespread use of the atypical antipsychotic drugs, diabetes was a major problem for persons with schizophrenia.
Keywords: Schizophrenia / diabetes / antipsychotics / hyperglycemia / health services
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. W. Bradford, M. M. Kim, L. E. Braxton, C. E. Marx, M. Butterfield, and E. B. Elbogen Access to Medical Care Among Persons With Psychotic and Major Affective Disorders Psychiatr Serv, August 1, 2008; 59(8): 847 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Dickerson, C. H. Brown, L. Fang, R. W. Goldberg, J. Kreyenbuhl, K. Wohlheiter, and L. Dixon Quality of Life in Individuals With Serious Mental Illness and Type 2 Diabetes Psychosomatics, April 1, 2008; 49(2): 109 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dickinson, J. M. Gold, F. B. Dickerson, D. Medoff, and L. B. Dixon Evidence of Exacerbated Cognitive Deficits in Schizophrenia Patients With Comorbid Diabetes Psychosomatics, April 1, 2008; 49(2): 123 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hippisley-Cox, Y. Vinogradova, C. Coupland, and C. Parker Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder: Nested Case-Control Study Arch Gen Psychiatry, December 1, 2007; 64(12): 1368 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Goldberg, B. Cooke, and A. Hackman Mental Health Providers' Involvement in Diabetes Management Psychiatr Serv, November 1, 2007; 58(11): 1501 - 1502. [Full Text] [PDF]
|
|
|
|
 |
|
 R. L Dufresne Weighing In: Emergent Diabetes Mellitus and Second-Generation Antipsychotics Ann. Pharmacother., October 1, 2007; 41(10): 1725 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Juvonen, A. Reunanen, J. Haukka, M. Muhonen, J. Suvisaari, R. Arajarvi, T. Partonen, and J. Lonnqvist Incidence of Schizophrenia in a Nationwide Cohort of Patients With Type 1 Diabetes Mellitus Arch Gen Psychiatry, August 1, 2007; 64(8): 894 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.H. Barnett, P. Mackin, I. Chaudhry, A. Farooqi, R. Gadsby, A. Heald, J. Hill, H. Millar, R. Peveler, A. Rees, et al. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia J Psychopharmacol, June 1, 2007; 21(4): 357 - 373. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Rettenbacher, M. Hummer, A. Hofer, S. Baumgartner, C. Ebenbichler, M. EdLinger, G. Kemmler, M. Lechleitner, and W. Wolfgang Fleischhacker Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study J Psychopharmacol, June 1, 2007; 21(4): 400 - 404. [Abstract] [PDF]
|
|
|
|
|
|
A. M. Fremont, A. S. Young, M. Chinman, P. Pantoja, S. Morton, P. Koegel, G. Sullivan, and D. Kanouse Differences in HIV Care Between Patients With and Without Severe Mental Illness Psychiatr Serv, May 1, 2007; 58(5): 681 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Goldberg, J. A. Kreyenbuhl, D. R. Medoff, F. B. Dickerson, K. Wohlheiter, L. J. Fang, C. H. Brown, and L. B. Dixon Quality of Diabetes Care Among Adults With Serious Mental Illness Psychiatr Serv, April 1, 2007; 58(4): 536 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. Jackson, N. H. Covell, R. E. Drake, and S. M. Essock Relationship Between Diabetes and Mortality Among Persons With Co-occurring Psychotic and Substance Use Disorders Psychiatr Serv, February 1, 2007; 58(2): 270 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Chwastiak, R. A. Rosenheck, J. P. McEvoy, R. S. Keefe, M. S. Swartz, and J. A. Lieberman Interrelationships of Psychiatric Symptom Severity, Medical Comorbidity, and Functioning in Schizophrenia Psychiatr Serv, August 1, 2006; 57(8): 1102 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Citrome, A. Jaffe, J. Levine, and D. Martello Incidence, Prevalence, and Surveillance for Diabetes in New York State Psychiatric Hospitals, 1997-2004 Psychiatr Serv, August 1, 2006; 57(8): 1132 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Krein, C. R. Bingham, J. F. McCarthy, A. Mitchinson, J. Payes, and M. Valenstein Diabetes Treatment Among VA Patients With Comorbid Serious Mental Illness Psychiatr Serv, July 1, 2006; 57(7): 1016 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Lamberti, D. Olson, J. F. Crilly, T. Olivares, G. C. Williams, X. Tu, W. Tang, K. Wiener, S. Dvorin, and M. B. Dietz Prevalence of the Metabolic Syndrome Among Patients Receiving Clozapine Am J Psychiatry, July 1, 2006; 163(7): 1273 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Cohen, R. P. Stolk, D. E. Grobbee, and C. C. Gispen-de Wied Hyperglycemia and Diabetes in Patients With Schizophrenia or Schizoaffective Disorders Diabetes Care, April 1, 2006; 29(4): 786 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gianfrancesco, J. Pesa, R.-H. Wang, and H. Nasrallah Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: Sensitivity to study design Am. J. Health Syst. Pharm., March 1, 2006; 63(5): 431 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Micca, V. P. Hoffmann, I. Lipkovich, J. Ahl, R. W. Baker, and T. A. Hardy Retrospective Analysis of Diabetes Risk in Elderly Patients With Dementia in Olanzapine Clinical Trials Am J Geriatr Psychiatry, January 1, 2006; 14(1): 62 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. G. Holt, C. Bushe, and L. Citrome Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol, November 1, 2005; 19(6_suppl): 56 - 65. [Abstract] [PDF]
|
|
|
|
|
|
V. J. Fedorowicz and E. Fombonne Metabolic side effects of atypical antipsychotics in children: a literature review J Psychopharmacol, September 1, 2005; 19(5): 533 - 550. [Abstract] [PDF]
|
|
|
|
|
|
H. A. Nasrallah, S. D. Targum, R. Tandon, J. S. McCombs, and R. Ross Defining and Measuring Clinical Effectiveness in the Treatment of Schizophrenia Psychiatr Serv, March 1, 2005; 56(3): 273 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Brook Testing for diabetes The British Journal of Psychiatry, January 1, 2005; 186(1): 78 - 79. [Full Text] [PDF]
|
|
|
|
|
|
D. R. Jones, C. Macias, P. J. Barreira, W. H. Fisher, W. A. Hargreaves, and C. M. Harding Prevalence, Severity, and Co-occurrence of Chronic Physical Health Problems of Persons With Serious Mental Illness Psychiatr Serv, November 1, 2004; 55(11): 1250 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Citrome, A. Jaffe, J. Levine, B. Allingham, and J. Robinson Relationship Between Antipsychotic Medication Treatment and New Cases of Diabetes Among Psychiatric Inpatients Psychiatr Serv, September 1, 2004; 55(9): 1006 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Akhtar, C. Kelly, A. Gallagher, and J. R Petrie Review: Newer antipsychotic agents, carbohydrate metabolism and cardiovascular risk The British Journal of Diabetes & Vascular Disease, September 1, 2004; 4(5): 303 - 309. [Abstract] [PDF]
|
|
|
|
|
|
L. B. Dixon, J. A. Kreyenbuhl, F. B. Dickerson, T. W. Donner, C. H. Brown, K. Wolheiter, L. Postrado, R. W. Goldberg, L. Fang, C. Marano, et al. A Comparison of Type 2 Diabetes Outcomes Among Persons With and Without Severe Mental Illnesses Psychiatr Serv, August 1, 2004; 55(8): 892 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Dinan Introduction The British Journal of Psychiatry, April 1, 2004; 184(47): s53 - s54. [Full Text] [PDF]
|
|
|
|
|
|
C. Bushe and R. Holt Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia The British Journal of Psychiatry, April 1, 2004; 184(47): s67 - s71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Haddad Antipsychotics and diabetes: review of non-prospective data The British Journal of Psychiatry, April 1, 2004; 184(47): s80 - s86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cavazzoni, N. Mukhopadhyay, C. Carlson, A. Breier, and J. Buse Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medications The British Journal of Psychiatry, April 1, 2004; 184(47): s94 - s101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gough and R. Peveler Diabetes and its prevention: pragmatic solutions for people with schizophrenia The British Journal of Psychiatry, April 1, 2004; 184(47): s106 - s111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. McCreadie Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study The British Journal of Psychiatry, December 1, 2003; 183(6): 534 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cradock-O'Leary, A. S. Young, E. M. Yano, M. Wang, and M. L. Lee Use of General Medical Services by VA Patients With Psychiatric Disorders Psychiatr Serv, July 1, 2002; 53(7): 874 - 878. [Abstract] [Full Text] [PDF]
|
|